Doug Bradley is the General Counsel and Secretary at IDRI. Prior to joining IDRI, Doug was Vice President & Intellectual Property Counsel at Unigen, Inc., a privately held, natural products discovery company. Previously, Doug was Assistant Counsel for Patent and Corporate Development & Licensing at Merck and Co., Inc.’s affiliate company, Rosetta Inpharmatics. Doug is experienced in all phases of intellectual property and licensing/contract law, in particular, negotiating and drafting of intellectual property licensing agreements, collaboration agreements, clinical trial agreements, supply and manufacturing agreements, and many other corporate agreements, intellectual property due diligence, strategic management of patent portfolios, patent application preparation and prosecution, and patent opinion work. Doug is admitted to the Washington State Bar Association and is a registered patent attorney with the United States Patent and Trademark Office.

Doug Bradley is the General Counsel and Secretary at IDRI. Prior to joining IDRI, Doug was Vice President & Intellectual Property Counsel at Unigen, Inc., a privately held, natural products discovery company. Previously, Doug was Assistant Counsel for Patent and Corporate Development & Licensing at Merck and Co., Inc.’s affiliate company, Rosetta Inpharmatics. Doug is experienced in all phases of intellectual property and licensing/contract law, in particular, negotiating and drafting of intellectual property licensing agreements, collaboration agreements, clinical trial agreements, supply and manufacturing agreements, and many other corporate agreements, intellectual property due diligence, strategic management of patent portfolios, patent application preparation and prosecution, and patent opinion work. Doug is admitted to the Washington State Bar Association and is a registered patent attorney with the United States Patent and Trademark Office.